Awareness, Acceptability and Uptake of Human Papilloma Virus Vaccine Among Cameroonian School-Attending Female Adolescents
The purpose of this study is to assess awareness, knowledge and beliefs about HPV, cervical cancer HPV vaccine and willingness to vaccinate among adolescent females aged 12–26 years at clinics and schools in the North West Region of Cameroon where the Cameroon Baptist Convention Health Services (CBCHS) conducted a sensitization and education campaign. A questionnaire survey was administered among female adolescents in schools and clinics. Descriptive statistics including frequencies, percentages and proportions were generated for independent variables and bivariate analyses (Chi square test) were used to assess the relationship between independent and outcome variables. Data were analyzed using SAS Version 9.2. Out of a sample of 650 adolescent girls 553 willingly participated in this anonymous survey. Awareness of HPV (86.8%), cervical cancer (82.3%), and prevention of HPV infections through vaccination (75.9%) was significantly higher than in previous studies conducted in Cameroon and other developing countries. Higher perceptions of risk were associated with being sexually active (p = 0.0013), age (p = 0.0031) and level of education (p = 0.0274). Age and educational level were associated with HPV knowledge (p = 0.007 and p = 0.0008), respectively. The mean level of interest in HPV vaccination was 4.0 (SD = 1.27), which is above the mean. Our data indicate high awareness about HPV, cervical cancer and HPV vaccine among adolescents, and interest in receiving the vaccine and learning about the disease. CBCHS’ community education strategy effectively raised acceptability and generated demand for HPV vaccine, making it a potential model for HPV immunization in Cameroon and other developing countries.
KeywordsHPV Cervical cancer Attitudes Vaccine Adolescents Cameroon
We thank the CBCHS for their support during the data collection fieldwork and the parents and school head teachers for allowing us to enroll their students in the study.
- 2.Parkin, D. M., Ferlay, J., Hamdi-Cherif, M., Sitas, F., Thomas, J., Wabinga, H, et al. (2003). Cancer in Africa: Epidemiology and prevention. IARC Press (IARC Scientific Publication No. 153).Google Scholar
- 6.WHO. (2010). WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Cameroon. Summary Report 2010. www.who.int/hpvcentre. Accessed 28 Aug 2011.
- 7.World Health Organization. (2002). Cervical cancer screening in developing countries: Report of a WHO consultation. Geneva: World Health Organization.Google Scholar
- 9.WHO. (2009). Human papillomavirus vaccines: WHO position paper. WHO Weekly epidemiological record, 84(15), 117–132.Google Scholar
- 17.Denny, L., Quinn, M., & Sankaranarayanan, R. (2006). Chapter 8: Screening for cervical cancer in developing countries. Vaccine, 24(Suppl 3), S3/71–S3/77.Google Scholar
- 19.Tebeu, P. M., Major, A. L., Rapiti, E., Petignat, P., Bouchardy, C., Sando, Z., et al. (2008). The attitude and knowledge of cervical cancer by Cameroonian women; a clinical survey conducted in Maroua, the capital of Far North Province of Cameroon. International Journal of Gynecological Cancer, 18(4), 761–765.PubMedCrossRefGoogle Scholar
- 22.Hawes, S. E., Critchlow, C. W., Sow, P. S., Toure, P., N’Doye, I., Diop, A., et al. (2006). Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2. Journal of the National Cancer Institute, 98(2), 100–109.PubMedCrossRefGoogle Scholar
- 23.Massad, L. S., Ahdieh, L., Benning, L., Minkoff, H., Greenblatt, R. M., Watts, H., et al. (2001). Evolution of cervical abnormalities among women with HIV-1: Evidence from surveillance cytology in the women’s interagency HIV study. Journal of Acquired Immune Deficiency Syndromes, 27(5), 432–442.PubMedCrossRefGoogle Scholar
- 25.Schuman, P., Ohmit, S. E., Klein, R. S., Duerr, A., Cu-Uvin, S., Jamieson, D. J., et al. (2003). Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. Journal of Infectious Diseases, 188(1), 128–136.PubMedCrossRefGoogle Scholar
- 27.Wamai, R., Ayissi, C. A., Oduwo, G. O., Perlman, S. M., Welty, E., Manga, S., et al. (2012). Assessing the effectiveness of a community-based sensitization strategy in creating awareness about HPV, cervical cancer and HPV vaccine among parents in North West Cameroon. Journal of Community Health [Epub ahead of print].Google Scholar
- 28.World Health Organization. (2006). Promotion RHWHOCDH: Comprehensive cervical cancer control: a guide to essential practice. Geneva: WHO.Google Scholar
- 29.Likert, R. (1932). A technique for the measurement of attitudes. Archives of psychology, 22(140), 1–55.Google Scholar
- 31.Parham, G. P., & Mwanahammuntu, M. (2004). Building a cervical cancer prevention program into the HIV care and treatment infrastructure in Zambia. From the Ground Up, 2, 429–445.Google Scholar
- 34.Blumenthal, P. D., Gaffikin, L., Deganus, S., Lewis, R., Emerson, M., & Adadevoh, S. (2007). Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. American Journal of Obstetrics and Gynecology, 196(4):407 e401–408; discussion 407 e408-409.Google Scholar
- 36.Mwanahamuntu, M. H., Sahasrabuddhe, V. V., & Parham, G. P. (2009). HPV screening for cervical cancer in rural India. The New England Journal of Medicine, 361(3):305; author reply 306.Google Scholar
- 40.Coleman, M. A., Levison, J., & Sangi-Haghpeykar, H. (2011). HPV vaccine acceptability in Ghana, West Africa. Vaccine, 29(23), 3945–3950.Google Scholar
- 42.Katahoire, R., Jitta, J., Kivumbi, G., Murokora, D., Arube, W. J., Siu, G., et al. (2010) An assessment of the readiness for introduction of the HPV vaccine in Uganda. African Journal of Reproductive Health, 12(3).Google Scholar
- 44.Cremer, M. L., Conlisk, E., & Felix, J. C. (2009) HPV screening for cervical cancer in rural India. The New England journal of medicine, 361(3):305; author reply 306.Google Scholar
- 45.Dell, D. L., Chen, H., Ahmad, F., & Stewart, D. E. (2009) Knowledge about human papillomavirus among adolescents. Obstetrics & gynecology, 96(5, Part 1):653.Google Scholar
- 46.Woodhall, S. C., Lehtinen, M., Verho, T., Huhtala, H., Hokkanen, M., & Kosunen, E. (2007). Anticipated acceptance of HPV vaccination at the baseline of implementation: A survey of parental and adolescent knowledge and attitudes in Finland. Journal of Adolescent Health, 40(5), 466–469.PubMedCrossRefGoogle Scholar
- 48.Blumenthal, J., Frey, M. K., Worley, M. J., Tchabo, N. E., Soren, K., & Slomovitz, B. M. (2012). Adolescent understanding and acceptance of the HPV vaccination in an underserved population in New York City. Journal of Oncology. doi: 10.1155/2012/904034.